Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169416
Status:
COMPLETED
Last Update Posted:
2015-04-15
First Post:
2005-09-09
Brief Title:
Evaluation Of Valaciclovir In Patients With Chickenpox
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Clinical Evaluation of Valaciclovir Hydrochloride 256U87 in Patients With Chickenpox - Open Uncontrolled Study
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety and efficacy and the pharmacokinetics of aciclovir and valaciclovir in children with chickenpox following oral administration of valaciclovir for the purpose of seeking approval of valaciclovir HCl for the treatment of chickenpox
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None